A Phase 2 pilot study at Holland Bloorview Kids Rehabilitation Hospital in Toronto is evaluating Rett-T, an antioxidant cocktail, compared with placebo in children and adolescents with Rett syndrome.

The study will explore the potential safety and effectiveness of Rett-T, including its impact on motor function, as well as other areas such as behaviour, anxiety, sleep and seizures.

Interested in learning more or finding out if your loved one may be eligible? 👉 View the full study details and eligibility criteria: ClinicalTrials.gov: NCT04041713

Please contact the study team directly for information about eligibility and enrollment.